What is Scimedx?
Scimedx Corporation is a seasoned diagnostic company with over 35 years of experience in In Vitro Diagnostics. The firm specializes in immunofluorescence, ELISA, and membrane technologies, focusing on autoimmune and infectious diseases. By harnessing the collective expertise of its personnel, Scimedx is dedicated to meeting laboratory needs through comprehensive product development, manufacturing, and distribution. Their product portfolio encompasses a variety of assays designed to advance diagnostic capabilities within modern healthcare.
How much funding has Scimedx raised?
Scimedx has raised a total of $357K across 2 funding rounds:
Debt
$150K
Debt
$207K
Debt (2020): $150K with participation from PPP
Debt (2021): $207K led by PPP
Key Investors in Scimedx
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Scimedx?
With a substantial large-scale late-stage funding context, Scimedx is poised for strategic growth and enhanced market penetration. The recent major strategic investment signals confidence from backers in the company's long-term vision and its capacity to innovate within the competitive diagnostic landscape. Future initiatives will likely involve expanding their assay offerings, optimizing manufacturing processes, and potentially exploring new technological frontiers to further solidify their role in healthcare diagnostics.
See full Scimedx company page
